Design, Implementation, Evaluation and Application of a 32-Channel Radio Frequency Signal Generator for Thermal Magnetic Resonance Based Anti-Cancer Treatment

• Main Authors: Haopeng Han, Thomas Wilhelm Eigentler, Shuailin Wang, Egor Kretov, Lukas Winter, Werner Hoffmann, Eckhard Grass, Thoralf Niendorf
• Format: Article
• Language: English
• Published: MDPI AG 2020-06-01
• Series: Cancers
• Subjects: thermal magnetic resonance; radio frequency heating; radio frequency signal generator; radio frequency antenna; hyperthermia
• Online Access: https://www.mdpi.com/2072-6694/12/7/1720

Thermal Magnetic Resonance (ThermalMR) leverages radio frequency (RF)-induced heating to examine the role of temperature in biological systems and disease. To advance RF heating with multi-channel RF antenna arrays and overcome the shortcomings of current RF signal sources, this work reports on a 32-channel modular signal generator (SG_PLL). The SG_PLL was designed around phase-locked loop (PLL) chips and a field-programmable gate array chip. To examine the system properties, switching/settling times, accuracy of RF power level and phase shifting were characterized. Electric field manipulation was successfully demonstrated in deionized water. RF heating was conducted in a phantom setup using self-grounded bow-tie RF antennae driven by the SG_PLL. Commercial signal generators limited to a lower number of RF channels were used for comparison. RF heating was evaluated with numerical temperature simulations and experimentally validated with MR thermometry. Numerical temperature simulations and heating experiments controlled by the SG_PLL revealed the same RF interference patterns. Upon RF heating similar temperature changes across the phantom were observed for the SG_PLL and for the commercial devices. To conclude, this work presents the first 32-channel modular signal source for RF heating. The large number of coherent RF channels, wide frequency range and accurate phase shift provided by the SG_PLL form a technological basis for ThermalMR controlled hyperthermia anti-cancer treatment.